abstract |
The invention discloses a new secreted polypeptide which was found upregulated in the CSF of Alzheimer's disease patients and which has therapeutic applications for the treatment of neurological disorders. The invention also provides methods of using compositions of the invention, including the polypeptides and polynucleotides encoding them, for drug development. |